Benjamin E. Johnson, MS, is affiliated with the College of Medicine at the University of Nebraska Medical Center in Omaha, Nebraska. Johnson has published research on addiction and phobic disorders, focusing on use disorders and withdrawal related to substances such as phenibut, bromazolam, and etizolam. His work includes clinical case studies involving medically supervised withdrawal and remission from multiple substance use disorders. Johnson has frequently collaborated with Alëna A. Balasanova and Sean McDermott in articles published by Psychiatrist.com.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
